라이프
전체기사 보기
-
Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims
Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning to a business process more aligned with regulatory requirements HONG KONG, Dec. 18, 2025 -- Cognizant (Nasdaq: CTSH) today announced a strategic collaboration with Bupa Hong Kong, a leading health insurance specialist in Hong Kong, to deliver Cognizant's first AI-driven Business-Process-as-a-Service (BPaaS) solution for claims modernization in the region. The five-year engagement represents the largest Intuitive Operations and Automation (IOA) services deal for Cognizant in Hong K
- 김갑성 기자
- 2025-12-18 08:00
-
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature
SAN FRANCISCO and SUZHOU, China, Dec. 18, 2025 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the results of two Phase 3 clinical studies of mazdutide, the world's first approved glucagon (GCG)/glucagon-like peptide-1 (GLP-1) dual receptor agonist, in Chinese adults with type 2 diabetes (T2D) (DREAMS-1, DREAMS-2) have been published back-
- 김갑성 기자
- 2025-12-18 08:00
-
Nabsys and Hitachi Present Electronic Genome Mapping Data at Japanese Society of Human Genetics (JSHG) 2025 Annual Meeting
TOKYO, Dec. 18, 2025 -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, in partnership with Hitachi High-Tech Corporation (HHT) announces the presentation of high resolution structural variation data on the OhmX(™) platform at the Japanese Society of Human Genetics (JSHG) Annual Meeting taking place on December 17-20, 2025, in Yokohama, Japan. In partnership with Dr. Catherine Brownstein, M.P.H., Ph.D. from Boston Children's Hospital, Nabsys and HHT will host a luncheon seminar on Thursday, December 18, 2025 from 12:25-1:25 PM at the Yokohama Confer
- 김갑성 기자
- 2025-12-18 05:05
-
PRISM BioLab and Talus Bioscience Join Forces to Discover Novel Inhibitors of Transcription Factor and Protein-Protein Interaction Targets
TOKYO, Dec. 18, 2025 -- PRISM BioLab, Co. Ltd. ("PRISM") and Talus Bioscience, Inc. ("Talus Bio") announced today that they entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and protein-protein interaction (PPI) targets. By combining Talus Bio's assay technologies for screening for TF and PPI inhibitors in native cellular environment with PRISM's chemistry designed to target protein-protein interactions, companies are in a unique position to discover and develop drugs against these challenging targets. Under
- 김갑성 기자
- 2025-12-18 00:00
-
Neutrinos Wins AI and Machine Learning Innovation Award at InsurInnovator Connect Vietnam 2025
Award recognizes Neutrinos' contribution to advancing AI adoption across the APAC region NEW YORK and SINGAPORE, Dec. 17, 2025 -- Neutrinos, a leader in AI-powered intelligent automation for insurers, has been recognized with the AI and Machine Learning Innovation Award at the IIC Vietnam Awards 2025. Held in conjunction with the annual InsurInnovator Connect Vietnam conference, the awards highlight innovations and initiatives that drive measurable progress and raise industry standards. Neutrinos received this recognition for its work in helping insurers operationalize
- 황정호 기자
- 2025-12-17 22:30
-
Datasea Advances Deployment of an Acoustics + AI-Driven Next-Generation Beauty & Health Intelligence System, Addressing a Multi-Billion-Dollar China Market Opportunity
BEIJING, Dec. 17, 2025 -- Datasea (Beijing) Technology Co., Ltd. ("Datasea"), a subsidiary of Datasea Inc. (NASDAQ: DTSS), today announced a strategic partnership with Shenzhen Yizhimei Technology Co., Ltd. ("Yizhimei"). Datasea will empower Yizhimei with its Acoustics + AI technologies to develop a next-generation Acoustics Digital AI Shampooing Robot and Beauty & Health Intelligence System, supporting the accelerated digital transformation of China's beauty and health industry. Leveraging Datasea's capabilities in acoustic high-tech innov
- 김갑성 기자
- 2025-12-17 22:30
-
Rona Therapeutics Unveils the Global First Bi-valent PCSK9-LPA siRNA into Clinical Development for Cardiovascular Risk Reduction
SHANGHAI and SANTA BARBARA, Calif., Dec. 17, 2025 -- Rona Therapeutics, a global leader in next-generation RNAi medicines, today announced the submission of RN5681 to the Australian Human Research Ethics Committee (HREC), advancing the company's first bi-valent siRNA into clinical development. The Phase 1 trial is expected to begin dosing in Q1 2026. RN5681 is a GalNAc-conjugated, dual-targeting siRNA designed to simultaneously silence both PCSK9 and LPA, two genetically validated and complementary drivers of atherosclerotic cardiovascular disease. By unifying LDL
- 김갑성 기자
- 2025-12-17 21:00
-
MEDI&GENE Announces Catalyze Agreement with Lilly to Advance Next-Generation Obesity Therapeutics
SEOUL, South Korea, Dec. 17, 2025 -- MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreement with Eli Lilly and Company (Lilly) to advance a next-generation therapeutic for obesity. MEDI&GENE's discovery platform is designed to unlock novel therapeutic pathways that have the potential to sustain long-term weight maintenance, lean mass maintenance, and durability of desired metabolic effects. Under the agreement, Lilly ExploR&D will bring Lilly's expertise in molecule
- 김갑성 기자
- 2025-12-17 21:00
-
GROWNSY Reaches 3 Million Households as Baby Care Brand Caps Breakthrough Year
[ 메디채널 김갑성 기자 ] Company credits parent feedback initiative and ISO 13485 medical-grade manufacturing standards for rapid growth NEW YORK, Dec. 17, 2025 -- Grownsy, a baby care products company specializing in creating innovative baby care products designed to fit seamlessly into modern family life., announced today that its products are now used in over 3 million households globally, marking a significant milestone in the company's strategic roadmap as they close out 2025. The growth follows a year in which GROWNSY implemented what it calls a "listener strategy" — s
- 김갑성 기자
- 2025-12-17 21:00
-
Bioptimus Unveils M-Optimus, a World Model for Biology
Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation The Unveiling of M-Optimus: Bioptimus has trained its inaugural World Model for biology - a foundation model that learns interactions across multiple languages of biology - marking a revolutionary first step in simulating the full complexity of human life. Early Access to a Limited Number of Pioneer Clients: Bioptimus is now inviting a select number of partners to join this exclusive early-access phase. Accelerat
- 김갑성 기자
- 2025-12-17 20:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-18_THU
- Xinhua Silk Road：中国東部・江西省で毎年開催されるワインをテーマにした民俗文化祭 08:12
- Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims 08:00
- Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims 08:00
- Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature 08:00
- 인피니스, 글로벌브랜드라이센싱선도국내대표기업도약 07:00
- Nabsys and Hitachi Present Electronic Genome Mapping Data at Japanese Society of Human Genetics (JSHG) 2025 Annual Meeting 05:05
- Hexagon Cup, 54 and International Padel Federation unite to create the Hexagon World Series, the sport's first official team circuit, unifying the padel calendar alongside Cupra FIP Tour and Premier Padel 01:56
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 18일 09시 40분